250 related articles for article (PubMed ID: 9344042)
1. Calcitriol enhancement of TPA-induced tumorigenic transformation is mediated through vitamin D receptor-dependent and -independent pathways.
Chang PL; Lee TF; Garretson K; Prince CW
Clin Exp Metastasis; 1997 Nov; 15(6):580-92. PubMed ID: 9344042
[TBL] [Abstract][Full Text] [Related]
2. 1 alpha,25-Dihydroxyvitamin D3 enhances 12-O-tetradecanoylphorbol-13-acetate- induced tumorigenic transformation and osteopontin expression in mouse JB6 epidermal cells.
Chang PL; Prince CW
Cancer Res; 1993 May; 53(10 Suppl):2217-20. PubMed ID: 8485706
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D analogs, 20-Epi-22-oxa-24a,26a,27a,-trihomo-1alpha,25(OH)2-vitamin D3, 1,24(OH)2-22-ene-24-cyclopropyl-vitamin D3 and 1alpha,25(OH)2-lumisterol3 prime NB4 leukemia cells for monocytic differentiation via nongenomic signaling pathways, involving calcium and calpain.
Berry DM; Meckling-Gill KA
Endocrinology; 1999 Oct; 140(10):4779-88. PubMed ID: 10499538
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin induction is required for tumor promoter-induced transformation of preneoplastic mouse cells.
Chang PL; Cao M; Hicks P
Carcinogenesis; 2003 Nov; 24(11):1749-58. PubMed ID: 12919959
[TBL] [Abstract][Full Text] [Related]
5. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
[TBL] [Abstract][Full Text] [Related]
6. 1 alpha,25-dihydroxyvitamin D3 stimulates synthesis and secretion of nonphosphorylated osteopontin (secreted phosphoprotein 1) in mouse JB6 epidermal cells.
Chang PL; Prince CW
Cancer Res; 1991 Apr; 51(8):2144-50. PubMed ID: 2009532
[TBL] [Abstract][Full Text] [Related]
7. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
8. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
Harant H; Spinner D; Reddy GS; Lindley IJ
J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
[TBL] [Abstract][Full Text] [Related]
9. Interrelationship between signal transduction pathways and 1,25(OH)2D3 in UMR106 osteoblastic cells.
Yang W; Hyllner SJ; Christakos S
Am J Physiol Endocrinol Metab; 2001 Jul; 281(1):E162-70. PubMed ID: 11404234
[TBL] [Abstract][Full Text] [Related]
10. Calcitriol regulation of osteopontin expression in mouse epidermal cells.
Chang PL; Ridall AL; Prince CW
Endocrinology; 1994 Sep; 135(3):863-9. PubMed ID: 8070379
[TBL] [Abstract][Full Text] [Related]
11. Transforming JB6 cells exhibit enhanced integrin-mediated adhesion to osteopontin.
Chang PL; Chambers AF
J Cell Biochem; 2000 Apr; 78(1):8-23. PubMed ID: 10797562
[TBL] [Abstract][Full Text] [Related]
12. Induction of anchorage-independent growth of JB6 mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3.
Hosoi J; Abe E; Suda T; Colburn NH; Kuroki T
Cancer Res; 1986 Nov; 46(11):5582-6. PubMed ID: 3019530
[TBL] [Abstract][Full Text] [Related]
13. 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis.
Takeyama K; Kitanaka S; Sato T; Kobori M; Yanagisawa J; Kato S
Science; 1997 Sep; 277(5333):1827-30. PubMed ID: 9295274
[TBL] [Abstract][Full Text] [Related]
14. Salt concentration determines 1,25-dihydroxyvitamin D3 dependency of vitamin D receptor-retinoid X receptor--vitamin D-responsive element complex formation.
Kimmel-Jehan C; Jehan F; DeLuca HF
Arch Biochem Biophys; 1997 May; 341(1):75-80. PubMed ID: 9143355
[TBL] [Abstract][Full Text] [Related]
15. Synergistic enhancement by 12-O-tetradecanoylphorbol-13-acetate and dibutyryl cAMP of 1alpha,25-dihydroxyvitamin D3 action in human promyelocytic leukemic HL-60 cells.
Hiura Y; Inaba M; Nishizawa Y; Otani S; Morii H
Endocr J; 1999 Apr; 46(2):317-24. PubMed ID: 10460017
[TBL] [Abstract][Full Text] [Related]
16. Effect of cellular environment on the selective activation of the vitamin D receptor by 1alpha,25-dihydroxyvitamin D3 and its analog 1alpha-fluoro-16-ene-20-epi-23-ene-26,27-bishomo-25-hydroxyvitamin D3 (Ro-26-9228).
Ismail A; Nguyen CV; Ahene A; Fleet JC; Uskokovic MR; Peleg S
Mol Endocrinol; 2004 Apr; 18(4):874-87. PubMed ID: 14726489
[TBL] [Abstract][Full Text] [Related]
17. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
[TBL] [Abstract][Full Text] [Related]
18. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change.
Bula CM; Bishop JE; Ishizuka S; Norman AW
Mol Endocrinol; 2000 Nov; 14(11):1788-96. PubMed ID: 11075812
[TBL] [Abstract][Full Text] [Related]
19. Target gene activation by 1,25-dihydroxyvitamin D3 in osteosarcoma cells is independent of calcium influx.
Khoury R; Ridall AL; Norman AW; Farach-Carson MC
Endocrinology; 1994 Dec; 135(6):2446-53. PubMed ID: 7988430
[TBL] [Abstract][Full Text] [Related]
20. 1alpha,25-dihydroxyvitamin D3 stimulates phosphorylation of IkappaBalpha and synergizes with TPA to induce nuclear translocation of NFkappaB during monocytic differentiation of NB4 leukemia cells.
Berry DM; Clark CS; Meckling-Gill KA
Exp Cell Res; 2002 Jan; 272(2):176-84. PubMed ID: 11777342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
